Literature DB >> 8524215

Association of the viral oncoprotein STP-C488 with cellular ras.

J U Jung1, R C Desrosiers.   

Abstract

The STP-C488 oncogene of herpesvirus saimiri has transforming activity independent of the rest of the viral genome. We now demonstrate that STP-C488 associates with cellular ras in transformed cells. Mutations that disrupted this association with ras disrupted the transforming ability of the STP-C488 oncogene. Binding assays showed that STP-C488 was capable of competing with raf-1 for binding to ras. Expression of STP-C488 activated the ras signaling pathway as evidenced by a two- to fourfold increase in the ratio of ras-GTP to ras-GDP and by the constitutive activation of mitogen-activated protein kinase. Consistent with an activation of signaling through ras, STP-C488 expression induced ras-dependent neurite outgrowth in PC12 cells. STP-C488 is the first virus-encoded protein shown to achieve oncogenic transformation via association with cellular ras.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8524215      PMCID: PMC230903          DOI: 10.1128/MCB.15.12.6506

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  48 in total

1.  Improved retroviral vectors for gene transfer and expression.

Authors:  A D Miller; G J Rosman
Journal:  Biotechniques       Date:  1989-10       Impact factor: 1.993

2.  In vitro immortalization of marmoset cells with three subgroups of herpesvirus saimiri.

Authors:  E Szomolanyi; P Medveczky; C Mulder
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

3.  Deletion mutants of herpesvirus saimiri define an open reading frame necessary for transformation.

Authors:  S C Murthy; J J Trimble; R C Desrosiers
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

4.  Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product.

Authors:  P Whyte; K J Buchkovich; J M Horowitz; S H Friend; M Raybuck; R A Weinberg; E Harlow
Journal:  Nature       Date:  1988-07-14       Impact factor: 49.962

5.  The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product.

Authors:  N Dyson; P M Howley; K Münger; E Harlow
Journal:  Science       Date:  1989-02-17       Impact factor: 47.728

6.  Association of human papillomavirus types 16 and 18 E6 proteins with p53.

Authors:  B A Werness; A J Levine; P M Howley
Journal:  Science       Date:  1990-04-06       Impact factor: 47.728

7.  The divergence between two oncogenic Herpesvirus saimiri strains in a genomic region related to the transforming phenotype.

Authors:  B Biesinger; J J Trimble; R C Desrosiers; B Fleckenstein
Journal:  Virology       Date:  1990-06       Impact factor: 3.616

8.  Accumulation of p21ras.GTP in response to stimulation with epidermal growth factor and oncogene products with tyrosine kinase activity.

Authors:  T Satoh; M Endo; M Nakafuku; T Akiyama; T Yamamoto; Y Kaziro
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

9.  The trk proto-oncogene encodes a receptor for nerve growth factor.

Authors:  R Klein; S Q Jing; V Nanduri; E O'Rourke; M Barbacid
Journal:  Cell       Date:  1991-04-05       Impact factor: 41.582

10.  Ras is essential for nerve growth factor- and phorbol ester-induced tyrosine phosphorylation of MAP kinases.

Authors:  S M Thomas; M DeMarco; G D'Arcangelo; S Halegoua; J S Brugge
Journal:  Cell       Date:  1992-03-20       Impact factor: 41.582

View more
  37 in total

1.  Activation of cJUN N-terminal kinase by herpes simplex virus type 1 enhances viral replication.

Authors:  T I McLean; S L Bachenheimer
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

Review 2.  Signaling activities of gammaherpesvirus membrane proteins.

Authors:  B Damania; J K Choi; J U Jung
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  The collagen repeat sequence is a determinant of the degree of herpesvirus saimiri STP transforming activity.

Authors:  J K Choi; S Ishido; J U Jung
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  Immortalization of human and rhesus macaque primary antigen-specific T cells by retrovirally transduced telomerase reverse transcriptase.

Authors:  Eugene V Barsov
Journal:  Curr Protoc Immunol       Date:  2011-11

5.  Epstein-Barr virus-encoded LMP1 regulates epithelial cell motility and invasion via the ERK-MAPK pathway.

Authors:  Christopher W Dawson; Louise Laverick; Mhairi A Morris; Giorgos Tramoutanis; Lawrence S Young
Journal:  J Virol       Date:  2008-01-16       Impact factor: 5.103

6.  The interleukin-17 gene of herpesvirus saimiri.

Authors:  A Knappe; C Hiller; H Niphuis; F Fossiez; M Thurau; S Wittmann; E M Kuhn; S Lebecque; J Banchereau; B Rosenwirth; B Fleckenstein; J Heeney; H Fickenscher
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

7.  Functional phenotype of transformed human alphabeta and gammadelta T cells determined by different subgroup C strains of herpesvirus Saimiri.

Authors:  H Fickenscher; C Bökel; A Knappe; B Biesinger; E Meinl; B Fleischer; B Fleckenstein; B M Bröker
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

8.  Substitution of ras for the herpesvirus saimiri STP oncogene in lymphocyte transformation.

Authors:  J Guo; K Williams; S M Duboise; L Alexander; R Veazey; J U Jung
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

9.  T-cell lymphoma caused by herpesvirus saimiri C488 independently of ie14/vsag, a viral gene with superantigen homology.

Authors:  A Knappe; M Thurau; H Niphuis; C Hiller; S Wittmann; E M Kuhn; B Rosenwirth; B Fleckenstein; J Heeney; H Fickenscher
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

10.  Herpesvirus ateles Tio can replace herpesvirus saimiri StpC and Tip oncoproteins in growth transformation of monkey and human T cells.

Authors:  Jens-Christian Albrecht; Brigitte Biesinger; Ingrid Müller-Fleckenstein; Doris Lengenfelder; Monika Schmidt; Bernhard Fleckenstein; Armin Ensser
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.